Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001085146-25-001361·PRIMECAP MANAGEMENT CO/CA/
Schedule 13G ownership disclosure
Rhythm Pharmaceuticals Inc
COM · CUSIP: 76243J105
Event date: 2024-12-31
- Filing-level shares
- 6,571,190
- Percent of class
- 10.69%
- PRIMECAP MANAGEMENT CO/CA/
Shares: 6,571,190 · Class: 10.69%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-001361
- Form type
- SCHEDULE 13G/A
- Filer
- PRIMECAP MANAGEMENT CO/CA/
- CIK
- CIK 763212
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership